OxyBand Technologies Signs Army Contract

SAN FRANCISCO, May 9 /PRNewswire/ -- OxyBand Technologies, Inc. today
announced that it has signed a contract with the United States Army to
evaluate the company's patented cutting edge wound healing technology for
battlefield and other military wounds. OxyBand Technologies has developed a
proprietary wound dressing that delivers pure oxygen gas into wounds for
faster healing. The OxyBand dressing has been shown in clinical trials to
accelerate healing and, in laboratory testing, to reduce bacteria for
infection. The OxyBand Wound Dressing has received FDA 510(k) clearance for
both prescription (Rx) and over the counter (OTC) marketing.
"This initial contract with the Army establishes a great position for
OxyBand to further demonstrate the OxyBand wound healing prowess and moves us
closer to our goal of providing a real benefit to the men and women defending
our country," said Dr. Amie Franklin, CEO of OxyBand Technologies.
OxyBand Technologies has developed a proprietary technology for packaging
pure oxygen into a discrete wound dressing using directionally permeable gas-
emitting reservoirs. The resulting dressing has been shown in randomized,
controlled double-blind trials to significantly accelerate wound healing,
reduce inflammation, redness and pain through the direct and sustained
application of pure oxygen over several days.
Funding under this new Army contract is for an evaluation of OxyBand
dressings for accelerated healing of battlefield and other wounds, which is of
concern to the U.S. military. OxyBand anticipates beginning work under the
contract with the United States Army Medical Research and Material Command
(USAMRMC) immediately. The clinical study evaluating OxyBand Dressings will be
conducted at the United States Army Institute for Surgical Research, (USAISR)
which is a part of the USAMRMC and is co-located with Brooke Army Medical
Center.
"As part of our overall program to improve the care given to wounded
military service members, we are looking forward to continuing to work with
OxyBand in order to determine the effect of their innovative dressing on wound
healing in burn patients. We see great potential in this approach for
delivering oxygen directly to wounds and are hopeful that it will have broad
applicability in acute wound care," said Dr David Baer, the Director for the
Office of Research for the US Army Institute of Surgical Research, Program
Area Manager for Bone and Soft Tissue Trauma Research, DTO Manager for Defense
Technology Objective MD.30 (Battlefield Treatment of Fractures and Soft Tissue
Trauma Care), STO Manager for Science and Technology for both Objective S and
F (Soft Tissue Trauma Care) and Battlefield Treatment of Fractures), an
affiliate member of the McGowan Institute for Regenerative Medicine in
Pittsburgh, PA.
The USAISR mission is to provide requirements-driven combat casualty care
medical solutions and products for injured soldiers, from self-aid through
definitive care across the full spectrum of military operations; provide
state-of-the-art trauma, burn, and critical care to Department of Defense
eficiaries around the world and civilians; and provide Burn Special Medical
Augmentation Response Teams.
"We are proud to be working with the USAMRMC and the USAISR," added Dr.
Franklin. "We are confident OxyBand Dressings can provide a needed solution
for accelerating healing of battlefield and other wounds and we look forward
to helping the men and women serving in the military."
For more information please contact OxyBand Technologies Inc. at
information@oxyband.com or at 415 283 3356.
SOURCE OxyBand Technologies, Inc.

OxyBand Technologies Inc., +1-415-283-3356, information@oxyband.com